Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis - Contacts and Locations

Home

Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis

This study has been completed.

Study NCT00010439. Last updated on December 26, 2007. Information provided by FDA Office of Orphan Products Development

Please refer to this study by its ClinicalTrials.gov identifier: NCT00010439

Locations


United States, South Carolina
	Medical University of South Carolina
	Charleston, South Carolina, United States, 29425

Sponsors and Collaborators

FDA Office of Orphan Products Development

Medical University of South Carolina

Investigators


Study Chair:	L. Lyndon Key, Jr.	Medical University of South Carolina